companydata.dkcompanydata.dk

BioPartner Nordic ApS: Financial statements 2023

CVR: 38153188

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

BioPartner Nordic ApS (CVR 38153188) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 241,844 and a net result of DKK 94,330 compared with DKK -42,541 the year before. The profit margin was 39%. Equity in the 2023 report amounted to DKK -21,014.

Revenue
DKK 241,844
Gross Profit
DKK 127,896
Profit/Loss
DKK 94,330
Equity
DKK -21,014
Total Assets
DKK 79,015

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023242K128K94K-21K-
2022--13K-43K-115K-
2021121K23K-11K5K-
2020240K78K56K-62K-
201958K-137K-167K-118K-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

BioPartner Nordic ApS: The 2022 annual report is outJul 2, 2023

BioPartner Nordic ApS has published its annual report for 2022. Gross profit came to DKK -13,217, and the net result was DKK -42,541.

About BioPartner Nordic ApS

BioPartner Nordic ApS is a Danish company of the type Anpartsselskab based in Hedehusene, founded in 2016. The company is registered under the industry Anden teknisk rådgivning. The management consists of John Holger Schultz. The company is owned by John Holger Schultz. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -7,778 and a net result of DKK -27,378 compared with DKK -79,721 the year before. Equity in the 2025 report amounted to DKK 22,622.

Source: annual report 2025, Danish Business Authority

Other financial years